- Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial2018 | Second Faculty of Medicine
- The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer2012 | Third Faculty of Medicine
- Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer2023 | Publication without faculty affiliation
- Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial2012 | Second Faculty of Medicine
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival2010 | Faculty of Medicine in Hradec Králové
- Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial2024 | Second Faculty of Medicine
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis2014 | First Faculty of Medicine
- THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial2022 | Faculty of Medicine in Hradec Králové
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial2018 | First Faculty of Medicine
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.2010 | First Faculty of Medicine
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis A Randomized Phase IIa Trial2015 | First Faculty of Medicine
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Central Library of Charles University
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis2008 | First Faculty of Medicine
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | Central Library of Charles University
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Faculty of Medicine in Pilsen
- Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma2018 | First Faculty of Medicine
- A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | First Faculty of Medicine
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL2009 | Third Faculty of Medicine
- The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial2019 | Faculty of Medicine in Pilsen
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial2015 | First Faculty of Medicine
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial2017 | Central Library of Charles University, First Faculty of Medicine
- Randomized, Placebo-Controlled, Phase 3 Trial of PI3Kδ Inhibitor Leniolisib for Activated PI3Kδ Syndrome2023 | Second Faculty of Medicine
- Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial2017 | Faculty of Medicine in Pilsen
- Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase 2 trial2006 | Faculty of Physical Education and Sport
- EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer2008 | Second Faculty of Medicine
- Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial2020 | Central Library of Charles University, Third Faculty of Medicine